NAYA Biosciences (NAYA) Competitors

Allurion Technologies (NYSE:ALUR) and NAYA Biosciences (NASDAQ:NAYA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment.

Does the media refer more to ALUR or NAYA?

In the previous week, Allurion Technologies had 14 more articles in the media than NAYA Biosciences. MarketBeat recorded 16 mentions for Allurion Technologies and 2 mentions for NAYA Biosciences. NAYA Biosciences' average media sentiment score of 1.29 beat Allurion Technologies' score of 0.27 indicating that NAYA Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allurion Technologies	2 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
NAYA Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, ALUR or NAYA?

NAYA Biosciences has lower revenue, but higher earnings than Allurion Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allurion Technologies	$34.75M	0.40	-$80.61M	-$12.00	-0.45
NAYA Biosciences	$6.23M	0.35	-$8.03M	N/A	N/A

Do analysts prefer ALUR or NAYA?

Allurion Technologies currently has a consensus target price of $71.88, suggesting a potential upside of 1,228.56%. NAYA Biosciences has a consensus target price of $2.00, suggesting a potential upside of 312.37%. Given Allurion Technologies' higher possible upside, equities research analysts clearly believe Allurion Technologies is more favorable than NAYA Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allurion Technologies	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
NAYA Biosciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is ALUR or NAYA more profitable?

Allurion Technologies has a net margin of -71.24% compared to NAYA Biosciences' net margin of -119.91%.

Company	Net Margins	Return on Equity	Return on Assets
Allurion Technologies	-71.24%	N/A	-56.75%
NAYA Biosciences	-119.91%	N/A	-41.72%

Do insiders and institutionals hold more shares of ALUR or NAYA?

21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by company insiders. Comparatively, 3.5% of NAYA Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, ALUR or NAYA?

Allurion Technologies has a beta of -0.62, meaning that its stock price is 162% less volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500.

Does the MarketBeat Community prefer ALUR or NAYA?

Allurion Technologies received 6 more outperform votes than NAYA Biosciences when rated by MarketBeat users. However, 100.00% of users gave NAYA Biosciences an outperform vote while only 87.50% of users gave Allurion Technologies an outperform vote.

Company	Underperform	Outperform
Allurion Technologies	Outperform Votes 7 87.50%	Underperform Votes 1 12.50%
NAYA Biosciences	Outperform Votes 1 100.00%	Underperform Votes No Votes

Summary

Allurion Technologies beats NAYA Biosciences on 10 of the 15 factors compared between the two stocks.